A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.
Researchers said the analysis lays bare a ‘decades-long-failure’ to tackle the overweight and obesity epidemic ...
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
It’s hard to remember a time before Ozempic, Wegovy, and other injectable drugs referred to as GLP-1 receptor agonists (that ...
A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...
Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback